Investing to become financially independent
Investing to become financially independent
This December, I am giving you my analysis of a Japanese stock that I acquired last year and with which I have already made a gain of 33%. I expect the share price to double again to reflect the intrinsic value of the company. I am still bullish on this […]
Members-only title analysis (December 2021) Read More »
The Price Earnings Ratio (PER), although widely used by investors, has several limitations, particularly regarding the possible manipulation of earnings and its retrospective nature. Despite its drawbacks, this easily accessible indicator remains a good starting point for financial analysis, but should not be used alone to make investment decisions.
Valuation indicators (2/9) Read More »
AstraZeneca, the pharmaceutical giant born from the merger of Astra AB and Zeneca PLC, has established itself as one of the world leaders in the sector with around 100,000 employees dedicated to the research, development and marketing of pharmaceutical products. The group presents solid financial indicators, with an attractive yield and a generous dividend distribution policy, although investors should be cautious due to the relative youth of its successive dividend increases.
Astrazeneca (NYSE:AZN) Read More »
Discover Sigma-Aldrich, the American giant in the production of chemicals and equipment for scientific research, present worldwide with over a million customers. Despite its defensive nature and reasonable volatility, the share currently offers a high valuation that merits careful monitoring before any investment.
Sigma-Aldrich (Nasdaq:SIAL) Read More »
Discover why Coca-Cola, the soft drink giant that sells more than a billion bottles a day, represents an attractive investment opportunity. From its surprising origins with John Pemberton to its current financial performance, dive into the full analysis of this iconic company that offers an attractive yield and stable dividend growth.
Coca-Cola: A buying opportunity to seize despite currency fluctuations Read More »
RPM International Inc, a multinational company specializing in high-performance coatings and building materials, is distinguished by 49 consecutive years of dividend increases. Despite relatively high volatility and significant international exposure, the company maintains a stable market position with globally distributed products and a diversified investor base.
RPM International (NYSE:RPM) Read More »
Sigma-Aldrich, a leading US producer of chemicals for scientific research, has a defensive profile with growing dividends and a global presence in over 100 countries. Despite its attractive attributes, notably low volatility and hedging against dollar fluctuations, the stock currently appears overvalued, with a relatively low dividend yield.
Sigma-Aldrich (Nasdaq:SIAL) Read More »
AstraZeneca, born from the merger between Astra AB and Zeneca PLC, is a pharmaceutical giant that offers an attractive long-term yield with a prudent dividend policy. The company, which has thousands of employees worldwide, presents an interesting profile for investors despite some volatility, with a consistent Price/Earnings ratio and promising growth prospects.
Astrazeneca (NYSE:AZN) Read More »
Français 
English 
Italiano 
Deutsch 
Español 
Português